Covered recipient · General Payments record
TIMOTHY SULLIVAN
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$2,686.27
- Reported across 141 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $493.86 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $170.48 | 12 |
| RxSight Inc | $145.26 | 1 |
| GLAUKOS CORPORATION | $105.14 | 1 |
| Ocular Therapeutix, Inc. | $35.48 | 2 |
| Amgen Inc. | $20.48 | 1 |
| Bausch & Lomb Americas Inc. | $17.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.16 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106181159 | CMS |
| ABBVIE INC. | $26.44 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106181161 | CMS |
| ABBVIE INC. | $8.58 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106181163 | CMS |
| ABBVIE INC. | $22.40 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106181165 | CMS |
| ABBVIE INC. | $7.41 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106181167 | CMS |
| ABBVIE INC. | $6.17 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106181169 | CMS |
| ABBVIE INC. | $23.83 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106181171 | CMS |
| ABBVIE INC. | $17.45 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106181173 | CMS |
| ABBVIE INC. | $4.90 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106181175 | CMS |
| ABBVIE INC. | $18.05 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106181177 | CMS |
| ABBVIE INC. | $7.82 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106181179 | CMS |
| ABBVIE INC. | $6.27 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106181181 | CMS |
| Amgen Inc. | $20.48 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116160705 | CMS |
| Bausch & Lomb Americas Inc. | $17.02 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140460534 | CMS |
| Glaukos Corporation | $105.14 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151978250 | CMS |
| Ocular Therapeutix, Inc. | $16.40 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148204009 | CMS |
| Ocular Therapeutix, Inc. | $19.08 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148204011 | CMS |
| RxSight Inc | $145.26 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144229152 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.